Cephalosporins & carbapenems
also: cefalexin · cefuroxime · ceftriaxone · ceftazidime · meropenem · carbapenem
Overview
Broader β-lactams — cephalosporins by generation (broadening Gram-negative cover) and the very-broad carbapenems (reserve agents). C. diff risk and the neonatal ceftriaxone caution are key.
Mechanism
β-lactams — inhibit cell-wall synthesis (PBP binding), bactericidal. Carbapenems are the broadest-spectrum β-lactams, stable to most β-lactamases.
The agents
oral
UTI/SSTI alternative; pregnancy UTI.
Surgical prophylaxis.
IV/IM
Meningitis (≥3 mo), gonorrhoea; AVOID in neonates (kernicterus) → cefotaxime.
Pseudomonas.
IV
ESBL/severe sepsis; seizure risk; low penicillin cross-reactivity.
Adverse effects
Cephalosporins are high-risk.
Cautions & contraindications
Cross-reactivity (low but real).
Kernicterus; precipitation.
Interactions
- Alcohol with some (disulfiram-like, rare)
Monitoring & kinetics
Allergy; renal function
Oral (cefalexin) / IV. Carbapenems reserve — antimicrobial stewardship.
Choosing it
Spectrum: 1st-gen (cefalexin): Gram+ & some Gram−. 3rd-gen (ceftriaxone): broad Gram−, crosses BBB (meningitis, gonorrhoea); ceftazidime adds Pseudomonas. Carbapenems (meropenem): very broad incl. ESBL + Pseudomonas + anaerobes. None cover MRSA (except ceftaroline); cephalosporins miss Listeria + atypicals.
Source: BNF — Cephalosporins / carbapenems